Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

Introduction: Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening condition needing long poly-chemotherapy regimens. As no systematic reviews/meta-analysis is available to comprehensively evaluate the role of delamanid (DLM), we evaluated its effectiveness and safety. Methods: We reviewe...

Full description

Bibliographic Details
Main Authors: Mohammad Javad Nasiri, Moein Zangiabadian, Erfan Arabpour, Sirus Amini, Farima Khalili, Rosella Centis, Lia D'Ambrosio, Justin T. Denholm, H. Simon Schaaf, Martin van den Boom, Xhevat Kurhasani, Margareth Pretti Dalcolmo, Seif Al-Abri, Jeremiah Chakaya, Jan-Willem Alffenaar, Onno Akkerman, Denise Rossato Silva, Marcela Muňoz-Torrico, Barbara Seaworth, Emanuele Pontali, Laura Saderi, Simon Tiberi, Alimuddin Zumla, Giovanni Battista Migliori, Giovanni Sotgiu
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:International Journal of Infectious Diseases
Subjects:
TB
MDR-TB
delamanid
bedaquiline
effectiveness
safety
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971222001254

Internet

http://www.sciencedirect.com/science/article/pii/S1201971222001254

Similar Items